Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting

OBJECTIVES: To assess incidence rates (IRs) of VTE in patients with rheumatoid arthritis (RA) on different DMARDs and DMARD switchers. METHODS: Adults with RA on a DMARD between 2007 and 2017 were studied in a US claims database. Conventional synthetic DMARD (csDMARD) users, first biologic/targeted...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Huifang, Danwada, Raghava, Guo, Dianlin, Curtis, Jeffrey R, Kilpatrick, Ryan D, Hendrickson, Barbara, Islam, Syed S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803007/
https://www.ncbi.nlm.nih.gov/pubmed/31673413
http://dx.doi.org/10.1136/rmdopen-2019-001013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6803007/
https://www.ncbi.nlm.nih.gov/pubmed/31673413
http://dx.doi.org/10.1136/rmdopen-2019-001013

Ejemplares similares